URL: http://antibodyregistry.org/AB_2893955
Proper Citation: (Leinco Technologies Cat# LT4000, RRID:AB_2893955)
Target Antigen: SARS-CoV-2 RBD
Clonality: recombinant monoclonal
Comments:
Applications: ELISA
Info: Anti-SARS-CoV-2 Spike RBD, clone 2381, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD).
We found {{ ctrl2.mentions.total_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-SARS-CoV-2 Spike RBD (Clone: 2381).
No alerts have been found for Anti-SARS-CoV-2 Spike RBD (Clone: 2381).
Source: Antibody Registry